Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments

Pandemic of coronavirus disease (COVID-19) is still pressing the healthcare systems worldwide. Thus far, the lack of available COVID-19-targeted treatments has led scientists to look through drug repositioning practices and exploitation of available scientific evidence for potential efficient drugs...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Marios Spanakis, Athina Patelarou, Evridiki Patelarou, Nikolaos Tzanakis
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
R
Accès en ligne:https://doaj.org/article/c8e11f03c1724e42be50bdc78ade76c4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!